Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Statement of Financial Position [Abstract]
Allowance for accounts receivable	$ 118,537	$ 87,520
Allowance for notes receivable, current	25,469	10,372
Accumulated amortization for other intangible assets	42,331	39,242
Allowance for notes receivable, non current	$ 2,239	$ 2,890
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock authorized (in shares)	200,000,000	200,000,000
Common stock issued (in shares)	76,821,000	76,533,000
Common stock outstanding (in shares)	70,671,000	73,203,000
Common stock in treasury (in shares)	6,150,000	3,330,000